Drugs / Ross River Virus (RRV) Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00717834 | Jun → Oct 2008 | Ross river fever | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01604746 Comparator | Jul 2012 → Apr 2013 | Ross river fever | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ross River Virus (RRV) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00717834 ↗ |
| Known as | RRV vaccine | “The primary objective of this study is to assess the safety and tolerability of the Ross River Virus (RRV) Vaccine in a healthy young adult population.” NCT00717834 ↗ |
| Modality | Vaccine | “Formalin-treated, UV-inactivated, whole-virion, Vero cell-derived, preservative free Ross River Virus (RRV) vaccine” NCT00717834 ↗ |
| Route | Intramuscular | “Two intramuscular injections” NCT00717834 ↗ |